Skip to content

Impact of Maxigesic on postoperative recovery as assessed by QoR-15K in gynecological laparoscopic surgery

Impact of Maxigesic on postoperative recovery as assessed by QoR-15K in gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009097
Enrollment
50
Registered
2024-01-05
Start date
2024-01-09
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In the Maxigesic group, a single vial (100ml) of Maxigesic solution is administered intravenously over a period of 15 minutes starting 10 minutes after the initiation of surgery. the control gr

Sponsors

Chonnam National University Hospital
Lead Sponsor
Chonnam National University Hospital Hwasun Hospital
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients aged 19 years and above scheduled for gynecological surgery under general anesthesia using laparoscopy as a regular surgical procedure. 2. Patients with American Society of Anesthesiologists (ASA) physical status classification 1-3. 3. Patients who have voluntarily provided written consent to participate in this clinical research study.

Exclusion criteria

Exclusion criteria: Patients with severe blood disorders, severe liver dysfunction, severe kidney dysfunction, severe congestive heart failure, or severe hypertension. Patients with a history of hypersensitivity or allergic reactions, such as asthma, urticaria, or allergies, to aspirin or other NSAIDs. Patients with a history of bronchial asthma or its equivalent. Patients with a history of gastrointestinal ulcers, gastrointestinal bleeding, or their equivalents. Pregnant women. Patients with physical disabilities or illiteracy. Other patients deemed unsuitable by the researchers.

Design outcomes

Primary

MeasureTime frame
The total QoR-15K score at 1 day after surgery;The total QoR-15K score at 2 day after surgery

Secondary

MeasureTime frame
The total amount of Fentanyl used during the first day after surgery;The average NRS (Numeric Rating Scale) score during the first day after surgery;The average PONV (Postoperative Nausea and Vomiting) score during the first day after surgery;The total amount of Fentanyl used during the second day after surgery;The average NRS (Numeric Rating Scale) score during the second day after surgery;The average PONV (Postoperative Nausea and Vomiting) score during the second day after surgery;The amount of remifentanil used during surgery;Post-anesthesia care unit admission time and total length of stay

Countries

Korea, Republic of

Contacts

Public Contactbo-eun kim

Chonnam National University Hospital

rlaqh9807@naver.com+82-62-220-6893

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026